NASDAQ:MASS
908 Devices Inc. Stock News
$6.85
-0.0300 (-0.436%)
At Close: May 17, 2024
908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
09:56am, Tuesday, 09'th May 2023
908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago.
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
09:47am, Tuesday, 07'th Mar 2023
908 Devices Inc. (MASS) delivered earnings and revenue surprises of -40.91% and 1.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
908 Devices to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
07:00am, Tuesday, 14'th Feb 2023
BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the four
908 Devices: The Bull Vs. Bear Tug Of War
04:39am, Tuesday, 14'th Feb 2023
908 Devices is a highly rated stock by Wall Street analysts. Seeking Alpha quant ratings state the stock "is at a high risk of performing badly."
908 Devices Inc. (MASS) Q3 2022 Earnings Call Transcript
03:23pm, Monday, 14'th Nov 2022
908 Devices Inc. (NASDAQ:MASS ) Q3 2022 Results Conference Call November 14, 2022 8:30 AM ET Company Participants Kelly Gura - IR Kevin Knopp - CEO and Co-Founder Joe Griffith - CFO Conference Call Pa
Why 908 Devices Stock Is Sinking Today
11:44am, Monday, 14'th Nov 2022
Investors didn't like the medical device maker's update.
908 Devices to Participate in Upcoming Investor Conferences
07:00am, Wednesday, 02'nd Nov 2022
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate
908 Devices Inc. (MASS) CEO Kevin Knopp on Q2 2022 Results - Earnings Call Transcript
02:17pm, Tuesday, 09'th Aug 2022
908 Devices Inc. (NASDAQ:MASS ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Chief Executive Officer & Co-Founder Joe G
908 Devices to Report Second Quarter 2022 Financial Results on August 9, 2022
07:00am, Tuesday, 19'th Jul 2022
BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report finan
908 Devices, Inc. (MASS) CEO Kevin Knopp on Q1 2022 Results - Earnings Call Transcript
03:24pm, Tuesday, 10'th May 2022
908 Devices, Inc. (NASDAQ:MASS ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Chief Executive Officer & Co-Founder Joe Gr
908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
09:47am, Tuesday, 10'th May 2022
908 Devices Inc. (MASS) delivered earnings and revenue surprises of 0% and 8.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
908 Devices to Report First Quarter Financial Results on May 10, 2022
07:00am, Tuesday, 12'th Apr 2022
BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report finan
Why 908 Devices Stock Rocketed 15% Higher Today
10:58pm, Tuesday, 08'th Mar 2022 The Motley Fool
The niche healthcare company delivers a pair of convincing beats in its fourth quarter results.
Why 908 Devices Stock Rocketed 15% Higher Today
05:58pm, Tuesday, 08'th Mar 2022
The niche healthcare company delivers a pair of convincing beats in its fourth quarter results.
Voyager, 908 Devices top healthcare gainers; Alector, Can-Fite BioPharma lead losers'' pack
03:04pm, Tuesday, 08'th Mar 2022 Seeking Alpha
Gainers: Voyager Therapeutics VYGR +22%. 908 Devices (MASS) +16%. Viemed Healthcare VMD +10%
